Thomas L. Holland

Thomas L. Holland, an infectious disease specialist and professor at Duke University, discusses the innovative treatment of complicated Staphylococcus aureus bacteremia using Dalbavancin. He shares insights from the groundbreaking DOTS trial, which compares this long-acting antibiotic to traditional IV therapies, highlighting its potential to improve patient outcomes and quality of life. The conversation also addresses challenges in treatment, particularly for vulnerable populations, and the urgency of developing safer options for this serious infection.